Consoldiated Statements of Cash Flows (USD $)	9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013
Operating activities:
Net income (loss)	$ (439,397)	$ 656,535
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation	19,937	20,161
Change in fair value of marketable securities	(57,120)
Amortization of debt discount	744,406	2,575,610
Amortization of financing costs	67,069	43,529
Gain on troubled debt restructuring		(2,714,461)
Gain on sale of subsidiary	(640,180)
Gain on settlement of liabilities	(300,686)	(1,493,608)
Change in fair value of derivative liabilities	(456,915)	68,855
Changes in operating assets and liabilities:
Accounts receivable	44,697	(2,850)
Marketable securities	(12,000)
Prepaid expenses and other current assets	10,575	(8,761)
Other assets	(4,102)	(95,338)
Accounts payable, other accrued liabilities	455,089	239,192
Accounts payable and accrued liabilities-related party	294,199	1,140
Due to Pension Benefit Guaranty Corporation	72,863	69,325
Net cash used in operating activities:	(201,565)	(640,671)
Cash flows from financing activities:
Proceeds from borrowings	354,575	602,000
Principal payments of debt	(163,008)	(36,034)
Proceeds from exercise of stock warrants		68,000
Net cash provided by financing activities	191,567	633,966
Decrease in cash and cash equivalents	(9,998)	(6,705)
Cash and cash equivalents at beginning of period	17,242	12,366
Cash and cash equivalents at the end of period	7,244	5,661
Supplemental disclosure of cash flow information:
Cash paid during the period for: Income taxes
Cash paid during the period for: Interest	59,835	7,182
Non-cash financing transactions:
Fair value of derivative liabilities to discount on debt	230,836	3,292,892
Conversion of accrued liabilities to debt	249,190
Conversion of debt to equity	287,500	1,291,878
Conversion of embedded derivative liabilities to equity	$ 300,920	$ 1,983,334